BRETT GURKIN: Open Payments
NPI 1053355719 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,321 in 153 payments from 14 companies in 2025. Trend: 2023 $1,621 · 2024 $1,719 · 2025 $2,321
Food & beverage: $2,182Education: $139
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 57 | $579 |
| E.R. Squibb & Sons, L.L.C. | 19 | $362 |
| Janssen Pharmaceuticals, Inc | 18 | $296 |
| Vanda Pharmaceuticals Inc. | 12 | $209 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $202 |
| Alkermes, Inc. | 9 | $198 |
| Otsuka America Pharmaceutical, Inc. | 14 | $148 |
| Novo Nordisk Inc | 1 | $123 |
| Neurocrine BioSciences, Inc. | 4 | $65 |
| Lundbeck LLC | 3 | $47 |
Products named: UZEDY, COBENFY, CAPLYTA, ARISTADA, INVEGA SUSTENNA, HETLIOZ, Wegovy, REXULTI.
Industry payments across NC — which companies pay providers there.
